BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Drug Development

  The International Myeloma Foundation Advocates Formal Approval Of Thalomid(R) For Multiple Myeloma

  November 15, 2005

   · 

  3 min read
• Biotech Bay

  BioGenex, Inc.'s Xmatrx(TM) System Provides Significant Advantage For Research

  November 15, 2005

   · 

  1 min read
• Policy

  GlaxoSmithKline Is First Company Certified By NCQA In Program Design For Medication Adherence

  November 15, 2005

   · 

  2 min read
• Policy

  Celgene Receives Approvable Letter From FDA For THALOMID(R) In Treatment Of Newly Diagnosed Multiple Myeloma; FDA Requests Labeling Changes

  November 15, 2005

   · 

  5 min read
• Business

  BioMS Medical Announces Third Quarter 2005 Results

  November 15, 2005

   · 

  1 min read
• Drug Development

  Hana Biosciences, Inc. Announces Positive Interim Results From A Phase I Trial Of Talotrexin (PT-523) In Relapsed Or Refractory Non-Small Cell Lung Cancer (NSCLC)

  November 15, 2005

   · 

  1 min read
• Biophage Pharma Inc. Announces New Development Breakthrough In Its PDS(R) Biosensors technology

  November 15, 2005

   · 

  1 min read
• Business

  MediGene AG Launches Eligard In Spain, Gets Milestone

  November 15, 2005

   · 

  1 min read
• BioForest

  Epigenomics AG Announces End Of VC Pooling

  November 15, 2005

   · 

  1 min read
• Business

  Actavis Reports Record Profits And EBITDA Margins In Third Quarter

  November 15, 2005

   · 

  1 min read